News

Could LDCT screening for lung cancer move decision out of the primary care office?

View on the News

Large potential benefit to patients

Dr. Vera De Palo

Dr. Vera De Palo, FCCP, comments: Routine radiographic screening for lung cancer has long been debated. On November 10, CMS announced a proposal to cover low-dose CT screening for asymptomatic patients with a high risk for lung cancer. The proposal stresses the documentation of multiple elements including the requirement for scheduling a counseling and shared decision-making session before issuing an order for the low-dose CT scanning. While the required elements are many, the potential benefit to patients is great. A CHEST press release welcoming the preliminary decision may be accessed at http://www.chestnet.org/News/Press-Releases/2014/11/CHEST-ATS-CMS-Lung-Cancer.

Dr. De Palo is CMO, Chief of Medicine at Signature Healthcare Brockton Hospital in Brockton, Massachussetts.


 

References

A counseling requirement included in Medicare’s proposed decision to cover screening for lung cancer with low-dose computed tomography could pull primary care physicians out of the decision loop.

The proposed national coverage decision from the Centers for Medicare & Medicaid Services, announced Nov. 10, includes a requirement that patients “receive a written order for [low-dose computed tomography screening] during a lung cancer screening counseling and shared decision making visit, furnished by a physician ... or qualified nonphysician practitioner.” CMS has proposed covering low-dose computed tomography (LDCT) screening only for certain high-risk patients, with strict limitations on eligibility.

A proposed CMS decision memo suggesting LDCT use in lung cancer screening may remove primary care physicians from the decision making. ©Sebastian Kaulitzki/thinkstockphotos.com

A proposed CMS decision memo suggesting LDCT use in lung cancer screening may remove primary care physicians from the decision making.

But the time requirement and questions on how this counseling would be covered could make it challenging for patients to make this decision alongside their primary care physician.

“One of the most interesting things in the Medicare requirement for payment focuses on the counseling visit,” said Steven Zeliadt, Ph.D., core investigator at Veterans Affairs Health Services Research & Development Services and professor at the University of Washington, Seattle. “That’s very different than other cancer screening tests, and for Medicare to really be encouraging that and requiring that is something providers and systems are going to have to figure out how to offer and make sure that [this] actually happens.”

Dr. Zeliadt said that he expects to see specialized screening centers similar to those related to pulmonary or mammography screening to gain traction. These will be the places that integrate both parts of the screening by conducting the LDCT test as well as providing the prescreen counseling. This differs from the model used for colon cancer and prostate cancer screening, where the consultation and decision to conduct screening tests are typically done with the primary care physician.

“The Medicare guidelines encourages that [counseling] as well, to make sure that that’s a visit that gets built in,” Dr. Zeliadt said.

Pages

Recommended Reading

DeSalvo leaves post to focus on Ebola response
MDedge Hematology and Oncology
ACA implementation hinges on election outcomes
MDedge Hematology and Oncology
Medicare finalizes $40 per month payments for patient care coordination
MDedge Hematology and Oncology
Malpractice climate: ‘Stable, but still dysfunctional’
MDedge Hematology and Oncology
Sharing is caring: A primer on EHR interoperability
MDedge Hematology and Oncology
Midterm ballot initiatives mostly favor physicians
MDedge Hematology and Oncology
Medicare inches closer to advance care planning payment
MDedge Hematology and Oncology
Supreme Court to hear ACA subsidy challenge
MDedge Hematology and Oncology
HHS cuts 2015 ACA enrollment estimates by a quarter
MDedge Hematology and Oncology
CMS proposes lung cancer screening with low-dose CT for high-risk patients
MDedge Hematology and Oncology

Related Articles